Chawla, Bharat <br/><br/>
Long-term weight loss observed with olanzapine orally disintegrating tablets in overweight patients with chronic schizophrenia. A 1 year open-label, prospective trial.  [electronic resource] 

 -  Human psychopharmacology  Apr 2008 
 - 211-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1099-1077 
<br/><br/><label>Standard No.: </label>10.1002/hup.921  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antipsychotic Agents--administration & dosage<br/>Benzodiazepines--administration & dosage<br/>Body Mass Index<br/>Chemistry, Pharmaceutical<br/>Chronic Disease<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Male<br/>Olanzapine<br/>Overweight--complications<br/>Prospective Studies<br/>Psychotic Disorders--complications<br/>Schizophrenia--complications<br/>Weight Loss--drug effects